| Target- | 
| MechanismImmunostimulants | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhasePreclinical | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
|  | 
| MechanismSARS-CoV-2 S protein modulators | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhasePreclinical | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
|  | 
|  | 
|  | 
|  | 
| Active Indication- | 
| Inactive Indication- | 
| Drug Highest PhasePreclinical | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
100 Clinical Results associated with GBiotech SARL
0  Patents (Medical) associated with GBiotech SARL
100 Deals associated with GBiotech SARL
100 Translational Medicine associated with GBiotech SARL